Skip to main content
. 2020 Oct 27;9(11):3453. doi: 10.3390/jcm9113453

Table 9.

Prevalence of positive anti-VCA IgG (>1.1 U/mL) results after six months of treatment in patients with a poor (PedACR 30/50) and good (PedACR 70/90) response to treatment; CI—confidence interval.

Group Patients with Positive Anti-VCA IgG Results (%)
(95% CI)
PedACR 30/50
n = 9
75.0%
(34.9–96.8%)
PedACR 70/90
n = 35
37.1%
(21.5–55.1%)
Total
(n = 44)
43.1%
(32.2–51.2%)

PedACR—American College of Rheumatology Pediatric Criteria; VCA—viral capsid antigen.